Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Xenon Pharmaceuticals Inc (XENE)

$8.76 0.02 (0.23%)

15:59 EDT XENE Stock Quote Delayed 15 Minutes

Volume:

Previous Close $8.76

Market Cap 154.28M

PE Ratio -5.84

EPS -1.5

Volume (Avg. Vol.) 43,600

Day's Range 8.69 - 9.00

52-Week Range 5.41 - 15.92

Dividend & Yield N/A (N/A)

XENE Stock Predictions, Articles, and Xenon Pharmaceuticals Inc News

From InvestorPlace
From the Web

Xenon Pharmaceuticals Inc (XENE) Plunges on Acne Drug Flop

By William White, InvestorPlace Writer Mar 24, 2017

Xenon Pharmaceuticals (XENE) stock was falling hard on Friday following results from a recent study of its acne drug XEN801.

Xenon Pharmaceuticals Inc. (XENE) Q2 2019 Earnings Call Transcript

From The Motley Fool Aug 7, 2019

XENE earnings call for the period ending June 30, 2019.

Xenon Pharmaceuticals (XENE) Shares Cross Below 200 DMA

From Market News Video Aug 5, 2019

In trading on Monday, shares of Xenon Pharmaceuticals Inc (XENE) crossed below their 200 day moving average of $8.97, changing hands as low as $8.85 per share. Xenon Pharmaceuticals Inc shares are currently trading off about 2.9% on the day..

Is Xenon Pharmaceuticals Inc.’s (NASDAQ:XENE) CEO Paid At A Competitive Rate?

From Simply Wall St Jul 18, 2019

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! In 2003 Simon Pimstone was appointed CEO<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-xene/xenon-pharmaceuticals/news/is-xenon-pharmaceuticals-inc-s-nasdaqxene-ceo-paid-at-a-competitive-rate/">Read More...</a></div>

Xenon Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for XENE

From Market News Video Jun 20, 2019

In trading on Thursday, shares of Xenon Pharmaceuticals Inc (XENE) crossed above their 200 day moving average of $9.42, changing hands as high as $9.78 per share. Xenon Pharmaceuticals Inc shares are currently trading up about 3.1% on the day..

Xenon Pharmaceuticals Inc. (XENE) Q1 2019 Earnings Call Transcript

From The Motley Fool May 15, 2019

XENE earnings call for the period ending March 31, 2019.

Xenon Pharma misses by $0.06

From Seeking Alpha May 7, 2019

Xenon Pharma (NASDAQ:XENE): Q1 GAAP EPS of -$0.42 misses by $0.06.Cash and cash equivalents and marketable securities of $110.4M.Press Release

Navellier Ratings

Powered by Portfolio Grader

Total Grade

C

Hold

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!